| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055027 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 03/18/2004 | US20040055023 Animal models which concurrently expresses insulin and glucokinase gene in muscle cells; treating pancreatic disorders |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054140 Neuronal differentiation regulating factor for treatment of central nervous system disorders |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054137 Chimeric protein for diagnosis and treatment of cancers and infections; immunotherapy |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases |
| 03/18/2004 | US20040053879 Lung resistance protein (LRP/MVP); gene therapy |
| 03/18/2004 | US20040053878 Zipper protein kindase and uses thereof |
| 03/18/2004 | US20040053877 Comprises Sendai virus (SeV) vector; analyzed using LacZ reporter gene and insulin-like growth factor; for treatment of neuromusclar disorders |
| 03/18/2004 | US20040053875 Comprises double-stranded RNA; extracted from HeLa cells |
| 03/18/2004 | US20040053874 Polynucleotide that hybridize with and inhibit gene expression for amphipathic dimeric glycoproteins |
| 03/18/2004 | US20040053873 Electroporation methods for introducing bioactive agents into cells |
| 03/18/2004 | US20040053872 Administering polynucletides that inhibit interactions polymerases with tRNA, to humans for prophylaxis of aquired immune deficiency syndrome |
| 03/18/2004 | US20040053870 CpG reduced plasmids and viral vectors |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053868 Administering polynucleotides, BCL genes or proteins, fusion proteins and/or carrier mixtures, as antiapoptotic agents |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053863 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 03/18/2004 | US20040053843 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/18/2004 | US20040053835 Reagents which regulate and bind to human NMDA receptor gene products can play role in preventing, ameliorating, or correcting dysfunctions or diseases including asthma, genito-urinary system disorders |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053297 Cytokine-like proteins |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053276 Comprises protein factors for diagnosis, prevention and treatment of cancers, infections, immunological, gastrointestinal, organ and endocrine disorders; animal models for disease |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053249 Fas ligand-fused proteins |
| 03/18/2004 | US20040053247 Markers for prostate cancer |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040052840 Preparations for oligonucleotide transfer |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052787 Screening for menstruation disorders; measurement nucleic acids or protein |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering |
| 03/18/2004 | US20040052773 Production of multi-chain protein from muscle |
| 03/18/2004 | US20040052765 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering |
| 03/18/2004 | US20040052764 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/18/2004 | US20040052763 Target antigens; vaccine |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497335A1 Formulation for funnelling nucleic acids into eukaryotic cells |
| 03/18/2004 | CA2497193A1 Methods and compositions for tissue regeneration |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2441469A1 Methods and compositions for treating alzheimer's disease |
| 03/17/2004 | EP1398379A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398371A1 Infectious HCV pseudo-particles containing functional E1, E2 envelope proteins |
| 03/17/2004 | EP1398041A1 Recombinant lentiviral vector pseudotyped with the hemagglutinin protein for gene transfer into the retina |
| 03/17/2004 | EP1398039A1 Morphogenic proteins for enhancing cognitive function |
| 03/17/2004 | EP1398025A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein |
| 03/17/2004 | EP1397507A1 Methods and compositions for treating cardiovascular disease using 10218 |
| 03/17/2004 | EP1397500A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 03/17/2004 | EP1397492A2 Modified and stabilized gdf propeptides and uses thereof |
| 03/17/2004 | EP1397489A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 03/17/2004 | EP1397488A1 Novel compounds for chemiluminescense procedures |
| 03/17/2004 | EP1397154A2 Abin-mediated hepatitis protection |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP1397043A2 Methods for genetic immunization |
| 03/17/2004 | EP1003558B1 Lipid-polyamide conjugates and compositions for nucleic acid delivery |
| 03/17/2004 | EP0975775B1 Regulatory system for inducible expression of genes with lambdoid promoters |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0866655B1 Murine model for human carcinoma |
| 03/17/2004 | EP0762881B1 Use of active agents for the manufacture of medicaments for the treatment of rheumatoid arthritis |
| 03/17/2004 | EP0731807B1 N-2 substituted purines |
| 03/17/2004 | CN1483040A Heart ankyrin repeat protein gene upstream sequence, carrier containing the same sequence and usage thereof |
| 03/17/2004 | CN1482249A Eukaryotic expression vector of ER-detented IV collagenase cellular antibody gene |
| 03/17/2004 | CN1482238A Preparation method for tumour cell comprising interleukin-23 gene and its use |
| 03/16/2004 | US6706947 Method for screening for agents against cancer using an immunosuppression animal model |
| 03/16/2004 | US6706922 Process of making a compound by forming a polymer from a template drug |
| 03/16/2004 | US6706868 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/16/2004 | US6706694 Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/16/2004 | US6706693 Vaccination by topical application of genetic vectors |
| 03/16/2004 | US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706682 Increasing or maintaining the blood supply in the penis |
| 03/16/2004 | US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706394 Method and apparatus for manufacture of magnetizable microparticles |
| 03/11/2004 | WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020999A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 03/11/2004 | WO2004020969A2 Production of nanoparticles having a defined number of ligands |
| 03/11/2004 | WO2004020733A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |